Recombinant CDK4 anticorps
Aperçu rapide pour Recombinant CDK4 anticorps (ABIN7127418)
Antigène
Voir toutes CDK4 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- CDK4 Recombinant Monoclonal Antibody
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human CDK4
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:5000, IP:1:200-1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CDK4 (Cyclin-Dependent Kinase 4 (CDK4))
-
Autre désignation
- CDK4
-
Sujet
-
Background: Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.
Aliases: Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3), CDK4
-
UniProt
- P11802
-
Pathways
- Cycle Cellulaire, Mitotic G1-G1/S Phases, Regulation of Cell Size
Antigène
-